Matrix metalloproteinase-9 promotes chronic lymphocytic leukemia b cell survival through its hemopexin domain - Test2 - elhamkhani - TriplyDB

Matrix metalloproteinase-9 promotes chronic lymphocytic leukemia b cell survival through its hemopexin domain

Matrix metalloproteinase-9 promotes chronic lymphocytic leukemia b cell survival through its hemopexin domain

http://www.wikidata.org/entity/Q24299490

about

The kinesin KIF9 and reggie/flotillin proteins regulate matrix degradation by macrophage podosomes.Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression Late SV40 factor (LSF) enhances angiogenesis by transcriptionally up-regulating matrix metalloproteinase-9 (MMP-9)Glycosylation of matrix metalloproteases and tissue inhibitors: present state, challenges and opportunities Rho, ROCK and actomyosin contractility in metastasis as drug targets Neutrophil-Derived Proteases in the Microenvironment of Pancreatic Cancer -Active Players in Tumor Progression The relationship between the MMP system, adrenoceptors and phosphoprotein phosphatases Moving targets: Emerging roles for MMPs in cancer progression and metastasis Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade High levels of the adhesion molecule CD44 on leukemic cells generate acute myeloid leukemia relapse after withdrawal of the initial transforming event Matrix metalloproteinase-9 is involved in chronic lymphocytic leukemia cell response to fludarabine and arsenic trioxide Matrix metalloproteinases: regulators of the tumor microenvironment The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia The diacylglycerol kinase α/atypical PKC/β1 integrin pathway in SDF-1α mammary carcinoma invasiveness.Neutrophil Gelatinase-Associated Lipocalin (NGAL), Pro-Matrix Metalloproteinase-9 (pro-MMP-9) and Their Complex Pro-MMP-9/NGAL in Leukaemias.Diverse matrix metalloproteinase functions regulate cancer amoeboid migration Exploiting biological diversity and genomic aberrations in chronic lymphocytic leukemia.A novel CD44-binding peptide from the pro-matrix metalloproteinase-9 hemopexin domain impairs adhesion and migration of chronic lymphocytic leukemia (CLL) cells.Tumorigenic and adhesive properties of heparanase.Zymography methods for visualizing hydrolytic enzymes.Lewis (y) antigen overexpression increases the expression of MMP-2 and MMP-9 and invasion of human ovarian cancer cells.Localizing matrix metalloproteinase activities in the pericellular environment.Matrix metalloproteinases regulate the formation of dendritic spine head protrusions during chemically induced long-term potentiation.Acute lymphoid leukemia cells with greater stem cell antigen-1 (Ly6a/Sca-1) expression exhibit higher levels of metalloproteinase activity and are more aggressive in vivo.Activation of toll-like receptor-2 by endogenous matrix metalloproteinase-2 modulates dendritic-cell-mediated inflammatory responses.Circular trimers of gelatinase B/matrix metalloproteinase-9 constitute a distinct population of functional enzyme molecules differentially regulated by tissue inhibitor of metalloproteinases-1.The Role of CD44 in the Pathophysiology of Chronic Lymphocytic Leukemia.High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse.Identification of matrix metalloproteinase inhibitors by chemical arrays.Mannose receptor 2 attenuates renal fibrosis Matrix Metalloproteinases 2 and 9 Polymorphism in Patients With Myeloproliferative Diseases: A STROBE-Compliant Observational Study.A 17-residue sequence from the matrix metalloproteinase-9 (MMP-9) hemopexin domain binds α4β1 integrin and inhibits MMP-9-induced functions in chronic lymphocytic leukemia B cells.Differential inhibition of activity, activation and gene expression of MMP-9 in THP-1 cells by azithromycin and minocycline versus bortezomib: A comparative study Peripheral membrane associations of matrix metalloproteinases.Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications.Prolyl-isomerase Pin1 controls Notch3 protein expression and regulates T-ALL progression.Gene expression profile induced by arsenic trioxide in chronic lymphocytic leukemia cells reveals a central role for heme oxygenase-1 in apoptosis and regulation of matrix metalloproteinase-9 Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases.Src family kinases and their role in hematological malignancies.

P2860

19854ab9854529afea3b9d51a0d4cbe7832ac955 b780c8eabb57cee9ff34280c49bceb5941f0cd21 f52c7a843284ee320e4cdf219aa54446e4d84a6b

P248

Q24310125-48264761-5AE5-4C7E-B517-AF46C2121980 Q24568374-0A6609DE-BB65-423A-ACE7-1C22CF9C6C36 Q24598701-1DCBC471-18AB-4A5B-B2EB-714D8A9EA446 Q26745510-50014E93-C95B-4F2F-9701-4E4F701A1EC6 Q26751189-3F5F9BA7-BC07-4E5D-8E40-DED34C8F4033 Q26765238-481E5F33-DE7B-4299-9A4B-8B8E27B9F2EC Q27003263-0FDF284C-C975-4231-97D3-6E7AC9B0AB0A Q27008735-B145D348-4B4F-4CBC-A468-E2208B104FC2 Q28288148-7E3BD51B-D7E8-48FA-90F5-71DEF6185831 Q28299462-E590434B-5EA1-4810-A267-435588551516 Q28539921-D2857338-3965-4EED-A091-D8BD5965123A Q29619858-6CF3C78D-0B3E-435D-8A62-20BE17C712AF Q33655756-F142BBFD-4974-499F-ADD6-A7C42871F846 Q33699564-CFEC0B4F-AC54-489A-A0AD-22B4213F3991 Q33820258-073F4D3F-2206-45FA-BD38-82CE48E4B2C6 Q33988511-D8F922ED-16D0-42A1-B03D-34884F64B0B5 Q34056568-A60443D8-1871-4F62-BC93-5F3DE92108BB Q34075901-C5319869-856A-4C89-9807-5DCBE7BB1CA6 Q34137792-D87CFBFA-2BCB-44C6-BCC3-3327A1DA231E Q34329995-36FF32FA-67A5-44D9-8A7D-F9049F138E25 Q34396078-7691BB1F-C360-4EA0-A3C9-F99CA5341928 Q34418625-36C4C9D3-CA5A-49BB-A89A-12C2A04881EF Q34733795-798FFFDC-3799-4FC4-9825-7B41592E9DB7 Q35106493-8D7CC859-DD89-4845-9994-512FFBD0C14C Q35106822-4A9D53E1-C260-4900-B9A3-E51154015762 Q35447969-355E3CEC-161D-46BA-8C2B-E1CEAFDA2AD4 Q35489417-53745E8B-1064-4F26-ADCC-9AC013CBD9E8 Q35528643-1DD554BE-F8BF-4A3F-BDF7-C2E748095529 Q35635079-C2DCD4DA-2106-479B-B1BD-A592DE03C5F0 Q35715763-E9E23882-B9C5-45FD-BDC6-D57A20050528 Q36152089-9BC2B290-1188-4346-AB59-876D2C06C57A Q36201708-11E94F66-BC3D-4DFD-A175-7803331720C7 Q36331820-012A7530-B61F-44CF-AC7B-710AF459781A Q36356192-D21A0ADF-C38B-410F-B9B9-81DFC2AD021A Q36689108-CFD4B258-7586-4C11-B85E-AB17A69A0FF6 Q36862781-7F83F894-CD8B-4A00-BE58-4958A2DDEBDC Q37257716-F1DEC45A-8BC5-4DE7-BFF3-A7D018F14FA8 Q37696319-54BE01A6-11DA-4C0A-A9C2-CDBEA3D91E2B Q37784801-244B1164-A692-4100-9701-BB60FB54A2A6 Q38217719-350E1AC1-715D-40F7-9BFC-4AAB43B0A9D7

P2860

Matrix metalloproteinase-9 promotes chronic lymphocytic leukemia b cell survival through its hemopexin domain

http://www.wikidata.org/entity/Q24299490

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Matrix metalloproteinase-9 pro ...... l through its hemopexin domain

@ast

Matrix metalloproteinase-9 pro ...... l through its hemopexin domain

@en

Matrix metalloproteinase-9 pro ...... l through its hemopexin domain

@en-gb

Matrix metalloproteinase-9 pro ...... l through its hemopexin domain

@nl

type

label

Matrix metalloproteinase-9 pro ...... l through its hemopexin domain

@ast

Matrix metalloproteinase-9 pro ...... l through its hemopexin domain

@en

Matrix metalloproteinase-9 pro ...... l through its hemopexin domain

@en-gb

Matrix metalloproteinase-9 pro ...... l through its hemopexin domain

@nl

prefLabel

Matrix metalloproteinase-9 pro ...... l through its hemopexin domain

@ast

Matrix metalloproteinase-9 pro ...... l through its hemopexin domain

@en

Matrix metalloproteinase-9 pro ...... l through its hemopexin domain

@en-gb

Matrix metalloproteinase-9 pro ...... l through its hemopexin domain

@nl

P1433

Q24299490-FB08DB57-0AFE-4777-8ED5-075C33B74122

P1476

Q24299490-8823C457-CA67-4744-AF51-52009D4F776D

P2093

Q24299490-01EF438D-2A5A-4EBA-BA9B-B30709E8E8CD

Q24299490-02E3E67A-5450-498E-BDD3-6221AE0F91E2

Q24299490-17E84116-3D94-4A55-ABC0-8C2E9F8A556E

Q24299490-3BB313BC-1D09-4ED6-A15A-6E0D801D544A

Q24299490-578B95DF-3490-47F3-95A5-AADA9B2AF780

Q24299490-7114D23F-2439-4BC5-BFE3-D66D34F168B7

Q24299490-9BF072F8-B965-4B21-A217-30B98A72B2FC

Q24299490-B6896D78-6FBD-4240-B94D-B60C172BF1C5

Q24299490-FE287368-A24F-4D77-B333-903721AF7720

P304

Q24299490-85CB9E24-3E14-4947-BDD5-AEC2DEBDA04E

P31

Q24299490-96FDA473-02DF-4D89-AF82-10526F5F4A83

P3181

Q24299490-3BCA865B-1933-4377-BEAB-9509834E9402

P356

Q24299490-A360809F-F910-44DC-A8AE-E99CAEEFE744

P407

Q24299490-CFADB553-6FBE-470B-8D93-AC89BD1C9991

P433

Q24299490-C751FAAF-6660-49E4-9E83-FD62A7A0AC9D

P478

Q24299490-21F9C406-E4FC-44B7-BF9D-14B0B03249EC

P50

Q24299490-D6E966F8-9F41-4C2C-A927-AF2A9ADE4655

P577

Q24299490-1B0FEB15-E75F-4887-8739-A6283E6439A7

P5875

Q24299490-A4AF898D-43CD-49F4-BABC-14C45EC35F7E

P698

Q24299490-D2166A54-7FDC-43EF-91D7-C359AE66442C

P921

Q24299490-4607E4C9-B8CC-4DB7-A73B-322D8D7315B4

Q24299490-90BA6F68-99A9-457E-9BEC-6B48F02C4B52

P3181

P356

J.CCR.2009.12.044

P1433

P1476

Matrix metalloproteinase-9 pro ...... l through its hemopexin domain

@en

P2093

Angeles García-Pardo

http://www.w3.org/2001/XMLSchema#string

Elke Roeb

http://www.w3.org/2001/XMLSchema#string

Estefanía Ugarte-Berzal

http://www.w3.org/2001/XMLSchema#string

Javier Redondo-Muñoz

http://www.w3.org/2001/XMLSchema#string

José A García-Marco

http://www.w3.org/2001/XMLSchema#string

Martin Roderfeld

http://www.w3.org/2001/XMLSchema#string

María José Terol

http://www.w3.org/2001/XMLSchema#string

Mercedes Hernández del Cerro

http://www.w3.org/2001/XMLSchema#string

Philippe E Van den Steen

http://www.w3.org/2001/XMLSchema#string

P304

160-72

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1119886

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.CCR.2009.12.044

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Ghislain Opdenakker

P577

2010-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41451405

http://www.w3.org/2001/XMLSchema#string

P698

20159608

http://www.w3.org/2001/XMLSchema#string

P921